Reports

Industry Research Reports

Global Affinity Chromatography Column for Mycotoxins Market Outlook, In‑Depth Analysis & Forecast to 2032

Global Affinity Chromatography Column for Mycotoxins Market Outlook, In‑Depth Analysis & Forecast to 2032

Industry: Food & Beverages

Published Date: 2026-03-24

Pages: 191 Pages

Report ld: 6277414

application for samples

Request Sample

Custom reports

Customized Report

  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected
  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected

Affinity Chromatography Column for Mycotoxins Market Size(US$)

den_QYR1
cagr

CAGR 2026-2032

6.0%

marketSize

Market Size,2032

USD 311

Million

Market Snapshot

Market Size in 2026 (Value)
US$ 220 million
Market Forecast in 2032(Value)
US$ 311 million
CAGR
6.0%
Years Considered
2021-2032
Base Year
2026
Forecast Period
2026-2032

Source: Secondary research, interviews with experts, and QYResearch analysis

The global Affinity Chromatography Column for Mycotoxins market is projected to grow from US$ 208 million in 2025 to US$ 311 million by 2032, at a CAGR of 6.0% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.

An Affinity Chromatography Column for Mycotoxins is a specialized chromatographic column designed for the selective separation and purification of mycotoxins from complex mixtures, such as food, feed, and agricultural products. Mycotoxins are toxic compounds produced by certain molds (fungi) that can contaminate crops and pose serious health risks to humans and animals. These columns use the principles of affinity chromatography, which relies on the specific interaction between the target molecule (in this case, mycotoxins) and a ligand that is immobilized on the stationary phase of the column.

From a downstream perspective, Food accounted for % of 2025 revenue, surging to US$ million by 2032 (CAGR: % from 2026–2032).

Affinity Chromatography Column for Mycotoxins leading manufacturers (including Gold Standard Diagnostics Horsham, LCTech, Shimadzu, Biotez Berlin, PerkinElmer, VICAM, Ring Biotechnology, R-Biopharm AG, CHROMATIFIC, Neogen, etc.), dominate supply; the top five capture approximately % of global revenue, with Gold Standard Diagnostics Horsham leading 2025 sales at US$ million.

Regional Outlook:

North America rose from US$ million in 2025 to a forecast US$ million by 2032 (CAGR %).

Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2025, % share rising to % by 2032), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).

Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2032 (CAGR %).

Report Includes:

This definitive report equips business leaders, decision-makers, and stakeholders with a 360° view of the global Affinity Chromatography Column for Mycotoxins market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2021–2025) and delivers forecasts through 2032, illuminating demand trends and growth drivers.

By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customer distribution pattern.

Granular regional insights cover five major markets (North America, Europe, APAC, South America, and MEA) with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.

Critical competitive intelligence profiles manufacturers (sales volume, revenue, margins, pricing strategies, and major customers) and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.

MARKET SEGMENTATION

By Company

  • Gold Standard Diagnostics Horsham
  • LCTech
  • Shimadzu
  • Biotez Berlin
  • PerkinElmer
  • VICAM
  • Ring Biotechnology
  • R-Biopharm AG
  • CHROMATIFIC
  • Neogen
  • Shenzhen Bioeasy Biotechnology
  • Kwinbon Biotechnology
  • Shandong Meizheng Bio-Tech
  • Shandong Lvdu Bio-Sciences & Technology
  • Beijing Nano-Ace Technology
  • Pribolab
  • Jiangsu Suwei Micro-Biology Research
  • BIOCOMMA
  • Jiangsu Wisdom Engineering & Technology
  • Anavo
  • Prufunglab
  • Femdetection
  • Welch Materials
  • Wuhan Huamei Wisherkon Biotech
  • Shandong Vnya Bio-technology

Consumption by Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Segment by Type

  • Aflatoxins
  • Ochratoxin
  • Zearalenone
  • Deoxynivalenol
  • Fumonisins
  • Others

Segment by Application

  • Food
  • Feed
  • Others

biaoTi CHAPTER OUTLINE

marn_i1

Chapter 1: Defines the Affinity Chromatography Column for Mycotoxins study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential

marn_i1

Chapter 2: Offers current market state, projects global revenue and sales to 2032, pinpointing high consumption regions and emerging market catalysts

marn_i1

Chapter 3: Dissects the manufacturer landscape: ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves

marn_i1

Chapter 4: Unlocks high margin product segments: compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks

marn_i1

Chapter 5: Targets downstream market opportunities: evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application

marn_i1

Chapter 6: North America: breaks down sales and revenue by Application and country, profiles key manufacturers and assesses growth drivers and barriers

marn_i1

Chapter 7: Europe: analyses regional sales, revenue and market by Application and manufacturers, flagging drivers and barriers

marn_i1

Chapter 8: Asia Pacific: quantifies sales and revenue by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas

marn_i1

Chapter 9: Central & South America: measures sales and revenue by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges

marn_i1

Chapter 10: Middle East and Africa: evaluates sales and revenue by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles

marn_i1

Chapter 11: Profiles manufacturers in depth: details product specs, sales, revenue, margins; top manufactures 2025 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments

marn_i1

Chapter 12: Supply chain: analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles

marn_i1

Chapter 13: Market dynamics: explores drivers, restraints, regulatory impacts, and risk mitigation strategies

marn_i1

Chapter 14: Actionable conclusions and strategic recommendations.

WHY THIS REPORT

Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:

Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:

Allocate capital strategically to high growth regions (Chapters 6-10) and margin rich segments (Chapter 5).

Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.

Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).

Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).

Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region
Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

den_ic6
Product mix optimization based on local practices
Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

den_ic6
Competitor tactics in fragmented vs. consolidated markets
Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

den_ic6
Full Research Coverage
Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

den_ic6
19 Years Industry Expertise
19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

den_ic6
24/7 Fast Report Delivery
24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

den_ic6
Localized Strategic Analysis
Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

den_ic6
den_biaoTiZhungShi

TABLE OF CONTENTS

muLu

1 Study Coverage

1.1 Introduction to Affinity Chromatography Column for Mycotoxins: Definition, Properties, and Key Attributes

1.2 Market Segmentation by Type

1.2.1 Global Affinity Chromatography Column for Mycotoxins Market Size by Type, 2021 vs 2025 vs 2032

1.2.2 Aflatoxins

1.2.3 Ochratoxin

1.2.4 Zearalenone

1.2.5 Deoxynivalenol

1.2.6 Fumonisins

1.2.7 Others

1.3 Market Segmentation by Application

1.3.1 Global Affinity Chromatography Column for Mycotoxins Market Size by Application, 2021 vs 2025 vs 2032

1.3.2 Food

1.3.3 Feed

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

muLu

2 Executive Summary

2.1 Global Affinity Chromatography Column for Mycotoxins Revenue Estimates and Forecasts (2021-2032)

2.2 Global Affinity Chromatography Column for Mycotoxins Revenue by Region

2.2.1 Revenue Comparison: 2021 vs 2025 vs 2032

2.2.2 Historical and Forecasted Revenue by Region (2021-2032)

2.2.3 Global Revenue-Based Market Share by Region (2021-2032)

2.3 Global Affinity Chromatography Column for Mycotoxins Sales Estimates and Forecasts (2021-2032)

2.4 Global Affinity Chromatography Column for Mycotoxins Sales by Region

2.4.1 Sales Comparison: 2021 vs 2025 vs 2032

2.4.2 Historical and Forecasted Sales by Region (2021-2032)

2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends

2.4.4 Global Sales Market Share by Region (2021-2032)

muLu

3 Competitive Landscape

3.1 Global Affinity Chromatography Column for Mycotoxins Sales by Manufacturers

3.1.1 Global Sales Volume by Manufacturers (2021-2026)

3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2025)

3.2 Global Affinity Chromatography Column for Mycotoxins Manufacturer Revenue Rankings and Tiers

3.2.1 Global Revenue (Value) by Manufacturers (2021-2026)

3.2.2 Global Key Manufacturer Revenue Ranking (2024 vs. 2025)

3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)

3.3 Manufacturer Profitability Profiles and Pricing Strategies

3.3.1 Gross Margin by Top Manufacturer (2021 vs 2025)

3.3.2 Manufacturer-Level Price Trends (2021-2026)

3.4 Key Manufacturers Manufacturing Base and Headquarters

3.5 Key Manufacturers Market Share by Product Type

3.5.1 Aflatoxins: Market Share by Key Manufacturers

3.5.2 Ochratoxin: Market Share by Key Manufacturers

3.5.3 Zearalenone: Market Share by Key Manufacturers

3.5.4 Deoxynivalenol: Market Share by Key Manufacturers

3.5.5 Fumonisins: Market Share by Key Manufacturers

3.5.6 Others: Market Share by Key Manufacturers

3.6 Global Affinity Chromatography Column for Mycotoxins Market Concentration and Dynamics

3.6.1 Global Market Concentration

3.6.2 Entrant/Exit Impact Analysis

3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment

muLu

4 Product Segmentation

4.1 Global Affinity Chromatography Column for Mycotoxins Sales Performance by Type

4.1.1 Global Affinity Chromatography Column for Mycotoxins Sales Volume by Type (2021-2032)

4.1.2 Global Affinity Chromatography Column for Mycotoxins Revenue by Type (2021-2032)

4.1.3 Global Average Selling Price (ASP) Trends by Type (2021-2032)

4.2 Product Technology Differentiation

4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk

4.3.1 High-Growth Niches and Adoption Drivers

4.3.2 Profitability Hotspots and Cost Drivers

4.3.3 Substitution Threats

muLu

5 Downstream Applications and Customers

5.1 Global Affinity Chromatography Column for Mycotoxins Sales by Application

5.1.1 Global Historical and Forecasted Sales by Application (2021-2032)

5.1.2 Global Sales Market Share by Application (2021-2032)

5.1.3 High-Growth Application Identification

5.1.4 Emerging Application Case Studies

5.2 Global Affinity Chromatography Column for Mycotoxins Revenue by Application

5.2.1 Global Historical and Forecasted Revenue by Application (2021-2032)

5.2.2 Revenue-Based Market Share by Application (2021-2032)

5.3 Global Pricing Dynamics by Application (2021-2032)

5.4 Downstream Customer Analysis

5.4.1 Top Customers by Region

5.4.2 Top Customers by Application

muLu

6 North America

6.1 North America Sales Volume and Revenue (2021-2032)

6.2 North America Key Manufacturers Sales Revenue in 2025

6.3 North America Affinity Chromatography Column for Mycotoxins Sales and Revenue by Application (2021-2032)

6.4 North America Growth Accelerators and Market Barriers

6.5 North America Affinity Chromatography Column for Mycotoxins Market Size by Country

6.5.1 North America Revenue by Country

6.5.2 North America Sales Trends by Country

6.5.3 US

6.5.4 Canada

6.5.5 Mexico

muLu

7 Europe

7.1 Europe Sales Volume and Revenue (2021-2032)

7.2 Europe Key Manufacturers Sales Revenue in 2025

7.3 Europe Affinity Chromatography Column for Mycotoxins Sales and Revenue by Application (2021-2032)

7.4 Europe Growth Accelerators and Market Barriers

7.5 Europe Affinity Chromatography Column for Mycotoxins Market Size by Country

7.5.1 Europe Revenue by Country

7.5.2 Europe Sales Trends by Country

7.5.3 Germany

7.5.4 France

7.5.5 U.K.

7.5.6 Italy

7.5.7 Russia

muLu

8 Asia-Pacific

8.1 Asia-Pacific Sales Volume and Revenue (2021-2032)

8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2025

8.3 Asia-Pacific Affinity Chromatography Column for Mycotoxins Sales and Revenue by Application (2021-2032)

8.4 Asia-Pacific Affinity Chromatography Column for Mycotoxins Market Size by Region

8.4.1 Asia-Pacific Revenue by Region

8.4.2 Asia-Pacific Sales Trends by Region

8.5 Asia-Pacific Growth Accelerators and Market Barriers

8.6 Southeast Asia

8.6.1 Southeast Asia Revenue by Country (2021 vs 2025 vs 2032)

8.6.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines

8.7 China

8.8 Japan

8.9 South Korea

8.10 China Taiwan

8.11 India

muLu

9 Central and South America

9.1 Central and South America Sales Volume and Revenue (2021-2032)

9.2 Central and South America Key Manufacturers Sales Revenue in 2025

9.3 Central and South America Affinity Chromatography Column for Mycotoxins Sales and Revenue by Application (2021-2032)

9.4 Central and South America Investment Opportunities and Key Challenges

9.5 Central and South America Affinity Chromatography Column for Mycotoxins Market Size by Country

9.5.1 Central and South America Revenue Trends by Country (2021 vs 2025 vs 2032)

9.5.2 Brazil

9.5.3 Argentina

muLu

10 Middle East and Africa

10.1 Middle East and Africa Sales Volume and Revenue (2021-2032)

10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2025

10.3 Middle East and Africa Affinity Chromatography Column for Mycotoxins Sales and Revenue by Application (2021-2032)

10.4 Middle East and Africa Investment Opportunities and Key Challenges

10.5 Middle East and Africa Affinity Chromatography Column for Mycotoxins Market Size by Country

10.5.1 Middle East and Africa Revenue Trends by Country (2021 vs 2025 vs 2032)

10.5.2 GCC Countries

10.5.3 Turkey

10.5.4 Egypt

10.5.5 South Africa

muLu

11 Corporate Profile

11.1 Gold Standard Diagnostics Horsham

11.1.1 Gold Standard Diagnostics Horsham Corporation Information

11.1.2 Gold Standard Diagnostics Horsham Business Overview

11.1.3 Gold Standard Diagnostics Horsham Affinity Chromatography Column for Mycotoxins Product Models, Descriptions and Specifications

11.1.4 Gold Standard Diagnostics Horsham Affinity Chromatography Column for Mycotoxins Sales, Price, Revenue and Gross Margin (2021-2026)

11.1.5 Gold Standard Diagnostics Horsham Affinity Chromatography Column for Mycotoxins Sales by Product in 2025

11.1.6 Gold Standard Diagnostics Horsham Affinity Chromatography Column for Mycotoxins Sales by Application in 2025

11.1.7 Gold Standard Diagnostics Horsham Affinity Chromatography Column for Mycotoxins Sales by Geographic Area in 2025

11.1.8 Gold Standard Diagnostics Horsham Affinity Chromatography Column for Mycotoxins SWOT Analysis

11.1.9 Gold Standard Diagnostics Horsham Recent Developments

11.2 LCTech

11.2.1 LCTech Corporation Information

11.2.2 LCTech Business Overview

11.2.3 LCTech Affinity Chromatography Column for Mycotoxins Product Models, Descriptions and Specifications

11.2.4 LCTech Affinity Chromatography Column for Mycotoxins Sales, Price, Revenue and Gross Margin (2021-2026)

11.2.5 LCTech Affinity Chromatography Column for Mycotoxins Sales by Product in 2025

11.2.6 LCTech Affinity Chromatography Column for Mycotoxins Sales by Application in 2025

11.2.7 LCTech Affinity Chromatography Column for Mycotoxins Sales by Geographic Area in 2025

11.2.8 LCTech Affinity Chromatography Column for Mycotoxins SWOT Analysis

11.2.9 LCTech Recent Developments

11.3 Shimadzu

11.3.1 Shimadzu Corporation Information

11.3.2 Shimadzu Business Overview

11.3.3 Shimadzu Affinity Chromatography Column for Mycotoxins Product Models, Descriptions and Specifications

11.3.4 Shimadzu Affinity Chromatography Column for Mycotoxins Sales, Price, Revenue and Gross Margin (2021-2026)

11.3.5 Shimadzu Affinity Chromatography Column for Mycotoxins Sales by Product in 2025

11.3.6 Shimadzu Affinity Chromatography Column for Mycotoxins Sales by Application in 2025

11.3.7 Shimadzu Affinity Chromatography Column for Mycotoxins Sales by Geographic Area in 2025

11.3.8 Shimadzu Affinity Chromatography Column for Mycotoxins SWOT Analysis

11.3.9 Shimadzu Recent Developments

11.4 Biotez Berlin

11.4.1 Biotez Berlin Corporation Information

11.4.2 Biotez Berlin Business Overview

11.4.3 Biotez Berlin Affinity Chromatography Column for Mycotoxins Product Models, Descriptions and Specifications

11.4.4 Biotez Berlin Affinity Chromatography Column for Mycotoxins Sales, Price, Revenue and Gross Margin (2021-2026)

11.4.5 Biotez Berlin Affinity Chromatography Column for Mycotoxins Sales by Product in 2025

11.4.6 Biotez Berlin Affinity Chromatography Column for Mycotoxins Sales by Application in 2025

11.4.7 Biotez Berlin Affinity Chromatography Column for Mycotoxins Sales by Geographic Area in 2025

11.4.8 Biotez Berlin Affinity Chromatography Column for Mycotoxins SWOT Analysis

11.4.9 Biotez Berlin Recent Developments

11.5 PerkinElmer

11.5.1 PerkinElmer Corporation Information

11.5.2 PerkinElmer Business Overview

11.5.3 PerkinElmer Affinity Chromatography Column for Mycotoxins Product Models, Descriptions and Specifications

11.5.4 PerkinElmer Affinity Chromatography Column for Mycotoxins Sales, Price, Revenue and Gross Margin (2021-2026)

11.5.5 PerkinElmer Affinity Chromatography Column for Mycotoxins Sales by Product in 2025

11.5.6 PerkinElmer Affinity Chromatography Column for Mycotoxins Sales by Application in 2025

11.5.7 PerkinElmer Affinity Chromatography Column for Mycotoxins Sales by Geographic Area in 2025

11.5.8 PerkinElmer Affinity Chromatography Column for Mycotoxins SWOT Analysis

11.5.9 PerkinElmer Recent Developments

11.6 VICAM

11.6.1 VICAM Corporation Information

11.6.2 VICAM Business Overview

11.6.3 VICAM Affinity Chromatography Column for Mycotoxins Product Models, Descriptions and Specifications

11.6.4 VICAM Affinity Chromatography Column for Mycotoxins Sales, Price, Revenue and Gross Margin (2021-2026)

11.6.5 VICAM Recent Developments

11.7 Ring Biotechnology

11.7.1 Ring Biotechnology Corporation Information

11.7.2 Ring Biotechnology Business Overview

11.7.3 Ring Biotechnology Affinity Chromatography Column for Mycotoxins Product Models, Descriptions and Specifications

11.7.4 Ring Biotechnology Affinity Chromatography Column for Mycotoxins Sales, Price, Revenue and Gross Margin (2021-2026)

11.7.5 Ring Biotechnology Recent Developments

11.8 R-Biopharm AG

11.8.1 R-Biopharm AG Corporation Information

11.8.2 R-Biopharm AG Business Overview

11.8.3 R-Biopharm AG Affinity Chromatography Column for Mycotoxins Product Models, Descriptions and Specifications

11.8.4 R-Biopharm AG Affinity Chromatography Column for Mycotoxins Sales, Price, Revenue and Gross Margin (2021-2026)

11.8.5 R-Biopharm AG Recent Developments

11.9 CHROMATIFIC

11.9.1 CHROMATIFIC Corporation Information

11.9.2 CHROMATIFIC Business Overview

11.9.3 CHROMATIFIC Affinity Chromatography Column for Mycotoxins Product Models, Descriptions and Specifications

11.9.4 CHROMATIFIC Affinity Chromatography Column for Mycotoxins Sales, Price, Revenue and Gross Margin (2021-2026)

11.9.5 CHROMATIFIC Recent Developments

11.10 Neogen

11.10.1 Neogen Corporation Information

11.10.2 Neogen Business Overview

11.10.3 Neogen Affinity Chromatography Column for Mycotoxins Product Models, Descriptions and Specifications

11.10.4 Neogen Affinity Chromatography Column for Mycotoxins Sales, Price, Revenue and Gross Margin (2021-2026)

11.10.5 Neogen Recent Developments

11.11 Shenzhen Bioeasy Biotechnology

11.11.1 Shenzhen Bioeasy Biotechnology Corporation Information

11.11.2 Shenzhen Bioeasy Biotechnology Business Overview

11.11.3 Shenzhen Bioeasy Biotechnology Affinity Chromatography Column for Mycotoxins Product Models, Descriptions and Specifications

11.11.4 Shenzhen Bioeasy Biotechnology Affinity Chromatography Column for Mycotoxins Sales, Price, Revenue and Gross Margin (2021-2026)

11.11.5 Shenzhen Bioeasy Biotechnology Recent Developments

11.12 Kwinbon Biotechnology

11.12.1 Kwinbon Biotechnology Corporation Information

11.12.2 Kwinbon Biotechnology Business Overview

11.12.3 Kwinbon Biotechnology Affinity Chromatography Column for Mycotoxins Product Models, Descriptions and Specifications

11.12.4 Kwinbon Biotechnology Affinity Chromatography Column for Mycotoxins Sales, Price, Revenue and Gross Margin (2021-2026)

11.12.5 Kwinbon Biotechnology Recent Developments

11.13 Shandong Meizheng Bio-Tech

11.13.1 Shandong Meizheng Bio-Tech Corporation Information

11.13.2 Shandong Meizheng Bio-Tech Business Overview

11.13.3 Shandong Meizheng Bio-Tech Affinity Chromatography Column for Mycotoxins Product Models, Descriptions and Specifications

11.13.4 Shandong Meizheng Bio-Tech Affinity Chromatography Column for Mycotoxins Sales, Price, Revenue and Gross Margin (2021-2026)

11.13.5 Shandong Meizheng Bio-Tech Recent Developments

11.14 Shandong Lvdu Bio-Sciences & Technology

11.14.1 Shandong Lvdu Bio-Sciences & Technology Corporation Information

11.14.2 Shandong Lvdu Bio-Sciences & Technology Business Overview

11.14.3 Shandong Lvdu Bio-Sciences & Technology Affinity Chromatography Column for Mycotoxins Product Models, Descriptions and Specifications

11.14.4 Shandong Lvdu Bio-Sciences & Technology Affinity Chromatography Column for Mycotoxins Sales, Price, Revenue and Gross Margin (2021-2026)

11.14.5 Shandong Lvdu Bio-Sciences & Technology Recent Developments

11.15 Beijing Nano-Ace Technology

11.15.1 Beijing Nano-Ace Technology Corporation Information

11.15.2 Beijing Nano-Ace Technology Business Overview

11.15.3 Beijing Nano-Ace Technology Affinity Chromatography Column for Mycotoxins Product Models, Descriptions and Specifications

11.15.4 Beijing Nano-Ace Technology Affinity Chromatography Column for Mycotoxins Sales, Price, Revenue and Gross Margin (2021-2026)

11.15.5 Beijing Nano-Ace Technology Recent Developments

11.16 Pribolab

11.16.1 Pribolab Corporation Information

11.16.2 Pribolab Business Overview

11.16.3 Pribolab Affinity Chromatography Column for Mycotoxins Product Models, Descriptions and Specifications

11.16.4 Pribolab Affinity Chromatography Column for Mycotoxins Sales, Price, Revenue and Gross Margin (2021-2026)

11.16.5 Pribolab Recent Developments

11.17 Jiangsu Suwei Micro-Biology Research

11.17.1 Jiangsu Suwei Micro-Biology Research Corporation Information

11.17.2 Jiangsu Suwei Micro-Biology Research Business Overview

11.17.3 Jiangsu Suwei Micro-Biology Research Affinity Chromatography Column for Mycotoxins Product Models, Descriptions and Specifications

11.17.4 Jiangsu Suwei Micro-Biology Research Affinity Chromatography Column for Mycotoxins Sales, Price, Revenue and Gross Margin (2021-2026)

11.17.5 Jiangsu Suwei Micro-Biology Research Recent Developments

11.18 BIOCOMMA

11.18.1 BIOCOMMA Corporation Information

11.18.2 BIOCOMMA Business Overview

11.18.3 BIOCOMMA Affinity Chromatography Column for Mycotoxins Product Models, Descriptions and Specifications

11.18.4 BIOCOMMA Affinity Chromatography Column for Mycotoxins Sales, Price, Revenue and Gross Margin (2021-2026)

11.18.5 BIOCOMMA Recent Developments

11.19 Jiangsu Wisdom Engineering & Technology

11.19.1 Jiangsu Wisdom Engineering & Technology Corporation Information

11.19.2 Jiangsu Wisdom Engineering & Technology Business Overview

11.19.3 Jiangsu Wisdom Engineering & Technology Affinity Chromatography Column for Mycotoxins Product Models, Descriptions and Specifications

11.19.4 Jiangsu Wisdom Engineering & Technology Affinity Chromatography Column for Mycotoxins Sales, Price, Revenue and Gross Margin (2021-2026)

11.19.5 Jiangsu Wisdom Engineering & Technology Recent Developments

11.20 Anavo

11.20.1 Anavo Corporation Information

11.20.2 Anavo Business Overview

11.20.3 Anavo Affinity Chromatography Column for Mycotoxins Product Models, Descriptions and Specifications

11.20.4 Anavo Affinity Chromatography Column for Mycotoxins Sales, Price, Revenue and Gross Margin (2021-2026)

11.20.5 Anavo Recent Developments

11.21 Prufunglab

11.21.1 Prufunglab Corporation Information

11.21.2 Prufunglab Business Overview

11.21.3 Prufunglab Affinity Chromatography Column for Mycotoxins Product Models, Descriptions and Specifications

11.21.4 Prufunglab Affinity Chromatography Column for Mycotoxins Sales, Price, Revenue and Gross Margin (2021-2026)

11.21.5 Prufunglab Recent Developments

11.22 Femdetection

11.22.1 Femdetection Corporation Information

11.22.2 Femdetection Business Overview

11.22.3 Femdetection Affinity Chromatography Column for Mycotoxins Product Models, Descriptions and Specifications

11.22.4 Femdetection Affinity Chromatography Column for Mycotoxins Sales, Price, Revenue and Gross Margin (2021-2026)

11.22.5 Femdetection Recent Developments

11.23 Welch Materials

11.23.1 Welch Materials Corporation Information

11.23.2 Welch Materials Business Overview

11.23.3 Welch Materials Affinity Chromatography Column for Mycotoxins Product Models, Descriptions and Specifications

11.23.4 Welch Materials Affinity Chromatography Column for Mycotoxins Sales, Price, Revenue and Gross Margin (2021-2026)

11.23.5 Welch Materials Recent Developments

11.24 Wuhan Huamei Wisherkon Biotech

11.24.1 Wuhan Huamei Wisherkon Biotech Corporation Information

11.24.2 Wuhan Huamei Wisherkon Biotech Business Overview

11.24.3 Wuhan Huamei Wisherkon Biotech Affinity Chromatography Column for Mycotoxins Product Models, Descriptions and Specifications

11.24.4 Wuhan Huamei Wisherkon Biotech Affinity Chromatography Column for Mycotoxins Sales, Price, Revenue and Gross Margin (2021-2026)

11.24.5 Wuhan Huamei Wisherkon Biotech Recent Developments

11.25 Shandong Vnya Bio-technology

11.25.1 Shandong Vnya Bio-technology Corporation Information

11.25.2 Shandong Vnya Bio-technology Business Overview

11.25.3 Shandong Vnya Bio-technology Affinity Chromatography Column for Mycotoxins Product Models, Descriptions and Specifications

11.25.4 Shandong Vnya Bio-technology Affinity Chromatography Column for Mycotoxins Sales, Price, Revenue and Gross Margin (2021-2026)

11.25.5 Shandong Vnya Bio-technology Recent Developments

muLu

12 Value Chain and Supply-Chain Analysis

12.1 Affinity Chromatography Column for Mycotoxins Industry Chain

12.2 Affinity Chromatography Column for Mycotoxins Upstream Materials Analysis

12.2.1 Raw Materials

12.2.2 Key Suppliers Market Share & Risk Assessment

12.3 Affinity Chromatography Column for Mycotoxins Integrated Production Analysis

12.3.1 Manufacturing Footprint Analysis

12.3.2 Regional Production Market Share (2021-2032)

12.3.3 Regulatory and Trade Policy Impact on Production

12.3.4 Production Technology Overview

12.3.5 Regional Cost Drivers

12.4 Affinity Chromatography Column for Mycotoxins Sales Channels and Distribution Networks

12.4.1 Sales Channels

12.4.2 Distributors

muLu

13 Affinity Chromatography Column for Mycotoxins Market Dynamics

13.1 Industry Trends and Evolution

13.2 Market Growth Drivers and Emerging Opportunities

13.3 Market Challenges, Risks, and Restraints

13.4 Impact of U.S. Tariffs

muLu

14 Key Findings in the Global Affinity Chromatography Column for Mycotoxins Study

muLu

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.1.1 Research Programs/Design

15.1.1.2 Market Size Estimation

15.1.1.3 Market Breakdown and Data Triangulation

15.1.2 Data Source

15.1.2.1 Secondary Sources

15.1.2.2 Primary Sources

15.2 Author Details

den_biaoTiZhungShi

TABLE OF FIGURES

muLu

List of Tables

Table 1. Global Affinity Chromatography Column for Mycotoxins Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Table 2. Global Affinity Chromatography Column for Mycotoxins Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Table 3. Global Affinity Chromatography Column for Mycotoxins Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 4. Global Affinity Chromatography Column for Mycotoxins Revenue by Region (US$ Million), 2021-2026
Table 5. Global Affinity Chromatography Column for Mycotoxins Revenue by Region (US$ Million), 2027-2032
Table 6. Global Affinity Chromatography Column for Mycotoxins Sales Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (K Units)
Table 7. Global Affinity Chromatography Column for Mycotoxins Sales by Region (K Units), 2021-2026
Table 8. Global Affinity Chromatography Column for Mycotoxins Sales by Region (K Units), 2027-2032
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 10. Global Affinity Chromatography Column for Mycotoxins Sales by Manufacturers (K Units), 2021-2026
Table 11. Global Affinity Chromatography Column for Mycotoxins Sales Share by Manufacturers (2021-2026)
Table 12. Global Affinity Chromatography Column for Mycotoxins Revenue by Manufacturers (US$ Million), 2021-2026
Table 13. Global Affinity Chromatography Column for Mycotoxins Revenue-Based Market Share by Manufacturers (2021-2026)
Table 14. Global Key Manufacturers’Ranking Shift (2024 vs. 2025) (Based on Revenue)
Table 15. Global Manufacturer by Tier (Tier 1, Tier 2, and Tier 3), based on Affinity Chromatography Column for Mycotoxins Revenue, 2025
Table 16. Global Affinity Chromatography Column for Mycotoxins Average Gross Margin (%) by Manufacturer (2021 vs 2025)
Table 17. Global Affinity Chromatography Column for Mycotoxins Average Selling Price (ASP) by Manufacturers (US$/Unit), 2021-2026
Table 18. Key Manufacturers Affinity Chromatography Column for Mycotoxins Manufacturing Base and Headquarters
Table 19. Global Affinity Chromatography Column for Mycotoxins Market Concentration Ratio (CR5)
Table 20. Key Market Entrant/Exit (2021-2025) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Affinity Chromatography Column for Mycotoxins Sales Volume by Type (K Units), 2021-2026
Table 23. Global Affinity Chromatography Column for Mycotoxins Sales Volume by Type (K Units), 2027-2032
Table 24. Global Affinity Chromatography Column for Mycotoxins Revenue by Type (US$ Million), 2021-2026
Table 25. Global Affinity Chromatography Column for Mycotoxins Revenue by Type (US$ Million), 2027-2032
Table 26. Technical Specifications by Key Product Type
Table 27. Global Affinity Chromatography Column for Mycotoxins Sales by Application (K Units), 2021-2026
Table 28. Global Affinity Chromatography Column for Mycotoxins Sales by Application (K Units), 2027-2032
Table 29. Affinity Chromatography Column for Mycotoxins High-Growth Sectors Demand CAGR (2026-2032)
Table 30. Global Affinity Chromatography Column for Mycotoxins Revenue by Application (US$ Million), 2021-2026
Table 31. Global Affinity Chromatography Column for Mycotoxins Revenue by Application (US$ Million), 2027-2032
Table 32. Top Customers by Region
Table 33. Top Customers by Application
Table 34. North America Affinity Chromatography Column for Mycotoxins Growth Accelerators and Market Barriers
Table 35. North America Affinity Chromatography Column for Mycotoxins Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 36. North America Affinity Chromatography Column for Mycotoxins Sales (K Units) by Country (2021 vs 2025 vs 2032)
Table 37. Europe Affinity Chromatography Column for Mycotoxins Growth Accelerators and Market Barriers
Table 38. Europe Affinity Chromatography Column for Mycotoxins Revenue Grow Rate (CAGR) by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 39. Europe Affinity Chromatography Column for Mycotoxins Sales (K Units) by Country (2021 vs 2025 vs 2032)
Table 40. Asia-Pacific Affinity Chromatography Column for Mycotoxins Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Asia-Pacific Affinity Chromatography Column for Mycotoxins Sales (K Units) by Country (2021 vs 2025 vs 2032)
Table 42. Asia-Pacific Affinity Chromatography Column for Mycotoxins Growth Accelerators and Market Barriers
Table 43. Southeast Asia Affinity Chromatography Column for Mycotoxins Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 44. Central and South America Affinity Chromatography Column for Mycotoxins Investment Opportunities and Key Challenges
Table 45. Central and South America Affinity Chromatography Column for Mycotoxins Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 46. Middle East and Africa Affinity Chromatography Column for Mycotoxins Investment Opportunities and Key Challenges
Table 47. Middle East and Africa Affinity Chromatography Column for Mycotoxins Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 48. Gold Standard Diagnostics Horsham Corporation Information
Table 49. Gold Standard Diagnostics Horsham Description and Major Businesses
Table 50. Gold Standard Diagnostics Horsham Product Models, Descriptions and Specifications
Table 51. Gold Standard Diagnostics Horsham Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 52. Gold Standard Diagnostics Horsham Sales Value Proportion by Product in 2025
Table 53. Gold Standard Diagnostics Horsham Sales Value Proportion by Application in 2025
Table 54. Gold Standard Diagnostics Horsham Sales Value Proportion by Geographic Area in 2025
Table 55. Gold Standard Diagnostics Horsham Affinity Chromatography Column for Mycotoxins SWOT Analysis
Table 56. Gold Standard Diagnostics Horsham Recent Developments
Table 57. LCTech Corporation Information
Table 58. LCTech Description and Major Businesses
Table 59. LCTech Product Models, Descriptions and Specifications
Table 60. LCTech Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 61. LCTech Sales Value Proportion by Product in 2025
Table 62. LCTech Sales Value Proportion by Application in 2025
Table 63. LCTech Sales Value Proportion by Geographic Area in 2025
Table 64. LCTech Affinity Chromatography Column for Mycotoxins SWOT Analysis
Table 65. LCTech Recent Developments
Table 66. Shimadzu Corporation Information
Table 67. Shimadzu Description and Major Businesses
Table 68. Shimadzu Product Models, Descriptions and Specifications
Table 69. Shimadzu Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 70. Shimadzu Sales Value Proportion by Product in 2025
Table 71. Shimadzu Sales Value Proportion by Application in 2025
Table 72. Shimadzu Sales Value Proportion by Geographic Area in 2025
Table 73. Shimadzu Affinity Chromatography Column for Mycotoxins SWOT Analysis
Table 74. Shimadzu Recent Developments
Table 75. Biotez Berlin Corporation Information
Table 76. Biotez Berlin Description and Major Businesses
Table 77. Biotez Berlin Product Models, Descriptions and Specifications
Table 78. Biotez Berlin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 79. Biotez Berlin Sales Value Proportion by Product in 2025
Table 80. Biotez Berlin Sales Value Proportion by Application in 2025
Table 81. Biotez Berlin Sales Value Proportion by Geographic Area in 2025
Table 82. Biotez Berlin Affinity Chromatography Column for Mycotoxins SWOT Analysis
Table 83. Biotez Berlin Recent Developments
Table 84. PerkinElmer Corporation Information
Table 85. PerkinElmer Description and Major Businesses
Table 86. PerkinElmer Product Models, Descriptions and Specifications
Table 87. PerkinElmer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 88. PerkinElmer Sales Value Proportion by Product in 2025
Table 89. PerkinElmer Sales Value Proportion by Application in 2025
Table 90. PerkinElmer Sales Value Proportion by Geographic Area in 2025
Table 91. PerkinElmer Affinity Chromatography Column for Mycotoxins SWOT Analysis
Table 92. PerkinElmer Recent Developments
Table 93. VICAM Corporation Information
Table 94. VICAM Description and Major Businesses
Table 95. VICAM Product Models, Descriptions and Specifications
Table 96. VICAM Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 97. VICAM Recent Developments
Table 98. Ring Biotechnology Corporation Information
Table 99. Ring Biotechnology Description and Major Businesses
Table 100. Ring Biotechnology Product Models, Descriptions and Specifications
Table 101. Ring Biotechnology Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 102. Ring Biotechnology Recent Developments
Table 103. R-Biopharm AG Corporation Information
Table 104. R-Biopharm AG Description and Major Businesses
Table 105. R-Biopharm AG Product Models, Descriptions and Specifications
Table 106. R-Biopharm AG Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 107. R-Biopharm AG Recent Developments
Table 108. CHROMATIFIC Corporation Information
Table 109. CHROMATIFIC Description and Major Businesses
Table 110. CHROMATIFIC Product Models, Descriptions and Specifications
Table 111. CHROMATIFIC Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 112. CHROMATIFIC Recent Developments
Table 113. Neogen Corporation Information
Table 114. Neogen Description and Major Businesses
Table 115. Neogen Product Models, Descriptions and Specifications
Table 116. Neogen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 117. Neogen Recent Developments
Table 118. Shenzhen Bioeasy Biotechnology Corporation Information
Table 119. Shenzhen Bioeasy Biotechnology Description and Major Businesses
Table 120. Shenzhen Bioeasy Biotechnology Product Models, Descriptions and Specifications
Table 121. Shenzhen Bioeasy Biotechnology Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 122. Shenzhen Bioeasy Biotechnology Recent Developments
Table 123. Kwinbon Biotechnology Corporation Information
Table 124. Kwinbon Biotechnology Description and Major Businesses
Table 125. Kwinbon Biotechnology Product Models, Descriptions and Specifications
Table 126. Kwinbon Biotechnology Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 127. Kwinbon Biotechnology Recent Developments
Table 128. Shandong Meizheng Bio-Tech Corporation Information
Table 129. Shandong Meizheng Bio-Tech Description and Major Businesses
Table 130. Shandong Meizheng Bio-Tech Product Models, Descriptions and Specifications
Table 131. Shandong Meizheng Bio-Tech Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 132. Shandong Meizheng Bio-Tech Recent Developments
Table 133. Shandong Lvdu Bio-Sciences & Technology Corporation Information
Table 134. Shandong Lvdu Bio-Sciences & Technology Description and Major Businesses
Table 135. Shandong Lvdu Bio-Sciences & Technology Product Models, Descriptions and Specifications
Table 136. Shandong Lvdu Bio-Sciences & Technology Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 137. Shandong Lvdu Bio-Sciences & Technology Recent Developments
Table 138. Beijing Nano-Ace Technology Corporation Information
Table 139. Beijing Nano-Ace Technology Description and Major Businesses
Table 140. Beijing Nano-Ace Technology Product Models, Descriptions and Specifications
Table 141. Beijing Nano-Ace Technology Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 142. Beijing Nano-Ace Technology Recent Developments
Table 143. Pribolab Corporation Information
Table 144. Pribolab Description and Major Businesses
Table 145. Pribolab Product Models, Descriptions and Specifications
Table 146. Pribolab Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 147. Pribolab Recent Developments
Table 148. Jiangsu Suwei Micro-Biology Research Corporation Information
Table 149. Jiangsu Suwei Micro-Biology Research Description and Major Businesses
Table 150. Jiangsu Suwei Micro-Biology Research Product Models, Descriptions and Specifications
Table 151. Jiangsu Suwei Micro-Biology Research Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 152. Jiangsu Suwei Micro-Biology Research Recent Developments
Table 153. BIOCOMMA Corporation Information
Table 154. BIOCOMMA Description and Major Businesses
Table 155. BIOCOMMA Product Models, Descriptions and Specifications
Table 156. BIOCOMMA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 157. BIOCOMMA Recent Developments
Table 158. Jiangsu Wisdom Engineering & Technology Corporation Information
Table 159. Jiangsu Wisdom Engineering & Technology Description and Major Businesses
Table 160. Jiangsu Wisdom Engineering & Technology Product Models, Descriptions and Specifications
Table 161. Jiangsu Wisdom Engineering & Technology Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 162. Jiangsu Wisdom Engineering & Technology Recent Developments
Table 163. Anavo Corporation Information
Table 164. Anavo Description and Major Businesses
Table 165. Anavo Product Models, Descriptions and Specifications
Table 166. Anavo Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 167. Anavo Recent Developments
Table 168. Prufunglab Corporation Information
Table 169. Prufunglab Description and Major Businesses
Table 170. Prufunglab Product Models, Descriptions and Specifications
Table 171. Prufunglab Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 172. Prufunglab Recent Developments
Table 173. Femdetection Corporation Information
Table 174. Femdetection Description and Major Businesses
Table 175. Femdetection Product Models, Descriptions and Specifications
Table 176. Femdetection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 177. Femdetection Recent Developments
Table 178. Welch Materials Corporation Information
Table 179. Welch Materials Description and Major Businesses
Table 180. Welch Materials Product Models, Descriptions and Specifications
Table 181. Welch Materials Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 182. Welch Materials Recent Developments
Table 183. Wuhan Huamei Wisherkon Biotech Corporation Information
Table 184. Wuhan Huamei Wisherkon Biotech Description and Major Businesses
Table 185. Wuhan Huamei Wisherkon Biotech Product Models, Descriptions and Specifications
Table 186. Wuhan Huamei Wisherkon Biotech Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 187. Wuhan Huamei Wisherkon Biotech Recent Developments
Table 188. Shandong Vnya Bio-technology Corporation Information
Table 189. Shandong Vnya Bio-technology Description and Major Businesses
Table 190. Shandong Vnya Bio-technology Product Models, Descriptions and Specifications
Table 191. Shandong Vnya Bio-technology Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 192. Shandong Vnya Bio-technology Recent Developments
Table 193. Key Raw Materials Distribution
Table 194. Raw Materials Key Suppliers
Table 195. Critical Raw Material Supplier Concentration (2025) & Risk Index
Table 196. Milestones in Production Technology Evolution
Table 197. Distributors List
Table 198. Market Trends and Market Evolution
Table 199. Market Drivers and Opportunities
Table 200. Market Challenges, Risks, and Restraints
Table 201. Research Programs/Design for This Report
Table 202. Key Data Information from Secondary Sources
Table 203. Key Data Information from Primary Sources
muLu

List of Figures

Figure 1. Affinity Chromatography Column for Mycotoxins Product Picture
Figure 2. Global Affinity Chromatography Column for Mycotoxins Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Figure 3. Aflatoxins Product Picture
Figure 4. Ochratoxin Product Picture
Figure 5. Zearalenone Product Picture
Figure 6. Deoxynivalenol Product Picture
Figure 7. Fumonisins Product Picture
Figure 8. Others Product Picture
Figure 9. Global Affinity Chromatography Column for Mycotoxins Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Figure 10. Food
Figure 11. Feed
Figure 12. Others
Figure 13. Affinity Chromatography Column for Mycotoxins Report Years Considered
Figure 14. Global Affinity Chromatography Column for Mycotoxins Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 15. Global Affinity Chromatography Column for Mycotoxins Revenue (US$ Million), 2021-2032
Figure 16. Global Affinity Chromatography Column for Mycotoxins Revenue (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Figure 17. Global Affinity Chromatography Column for Mycotoxins Revenue-Based Market Share by Region (2021-2032)
Figure 18. Global Affinity Chromatography Column for Mycotoxins Sales (K Units), 2021-2032
Figure 19. Global Affinity Chromatography Column for Mycotoxins Sales (CAGR) by Region: 2021 vs 2025 vs 2032 (K Units)
Figure 20. Global Affinity Chromatography Column for Mycotoxins Sales Market Share by Region (2021-2032)
Figure 21. Top 5 and Top 10 Manufacturers Affinity Chromatography Column for Mycotoxins Sales Volume Market Share in 2025
Figure 22. Global Affinity Chromatography Column for Mycotoxins Revenue-Based Market Share Ranking (2025)
Figure 23. Tier Distribution by Revenue Contribution (2021 vs 2025)
Figure 24. Aflatoxins Revenue-Based Market Share by Manufacturer in 2025
Figure 25. Ochratoxin Revenue-Based Market Share by Manufacturer in 2025
Figure 26. Zearalenone Revenue-Based Market Share by Manufacturer in 2025
Figure 27. Deoxynivalenol Revenue-Based Market Share by Manufacturer in 2025
Figure 28. Fumonisins Revenue-Based Market Share by Manufacturer in 2025
Figure 29. Others Revenue-Based Market Share by Manufacturer in 2025
Figure 30. Global Affinity Chromatography Column for Mycotoxins Sales Volume-Based Market Share by Type (2021-2032)
Figure 31. Global Affinity Chromatography Column for Mycotoxins Revenue-Based Market Share by Type (2021-2032)
Figure 32. Global Affinity Chromatography Column for Mycotoxins ASP by Type (US$/Unit), 2021-2032
Figure 33. Global Affinity Chromatography Column for Mycotoxins Revenue-Based Market Share (2021-2032)
Figure 34. Global Affinity Chromatography Column for Mycotoxins Sales Market Share by Application (2021-2032)
Figure 35. Global Affinity Chromatography Column for Mycotoxins Revenue-Based Market Share by Application (2021-2032)
Figure 36. Global Affinity Chromatography Column for Mycotoxins ASP by Application (US$/Unit), 2021-2032
Figure 37. North America Affinity Chromatography Column for Mycotoxins Sales YoY (K Units), 2021-2032
Figure 38. North America Affinity Chromatography Column for Mycotoxins Revenue YoY (US$ Million), 2021-2032
Figure 39. North America Top 5 Manufacturers Affinity Chromatography Column for Mycotoxins Sales Revenue (US$ Million) in 2025
Figure 40. North America Affinity Chromatography Column for Mycotoxins Sales Volume (K Units) by Application (2021-2032)
Figure 41. North America Affinity Chromatography Column for Mycotoxins Sales Revenue (US$ Million) by Application (2021-2032)
Figure 42. US Affinity Chromatography Column for Mycotoxins Revenue (US$ Million), 2021-2032
Figure 43. Canada Affinity Chromatography Column for Mycotoxins Revenue (US$ Million), 2021-2032
Figure 44. Mexico Affinity Chromatography Column for Mycotoxins Revenue (US$ Million), 2021-2032
Figure 45. Europe Affinity Chromatography Column for Mycotoxins Sales YoY (K Units), 2021-2032
Figure 46. Europe Affinity Chromatography Column for Mycotoxins Revenue YoY (US$ Million), 2021-2032
Figure 47. Europe Top 5 Manufacturers Affinity Chromatography Column for Mycotoxins Sales Revenue (US$ Million) in 2025
Figure 48. Europe Affinity Chromatography Column for Mycotoxins Sales Volume (K Units) by Application (2021-2032)
Figure 49. Europe Affinity Chromatography Column for Mycotoxins Sales Revenue (US$ Million) by Application (2021-2032)
Figure 50. Germany Affinity Chromatography Column for Mycotoxins Revenue (US$ Million), 2021-2032
Figure 51. France Affinity Chromatography Column for Mycotoxins Revenue (US$ Million), 2021-2032
Figure 52. U.K. Affinity Chromatography Column for Mycotoxins Revenue (US$ Million), 2021-2032
Figure 53. Italy Affinity Chromatography Column for Mycotoxins Revenue (US$ Million), 2021-2032
Figure 54. Russia Affinity Chromatography Column for Mycotoxins Revenue (US$ Million), 2021-2032
Figure 55. Asia-Pacific Affinity Chromatography Column for Mycotoxins Sales YoY (K Units), 2021-2032
Figure 56. Asia-Pacific Affinity Chromatography Column for Mycotoxins Revenue YoY (US$ Million), 2021-2032
Figure 57. Asia-Pacific Top 8 Manufacturers Affinity Chromatography Column for Mycotoxins Sales Revenue (US$ Million) in 2025
Figure 58. Asia-Pacific Affinity Chromatography Column for Mycotoxins Sales Volume (K Units) by Application (2021-2032)
Figure 59. Asia-Pacific Affinity Chromatography Column for Mycotoxins Sales Revenue (US$ Million) by Application (2021-2032)
Figure 60. Indonesia Affinity Chromatography Column for Mycotoxins Revenue (US$ Million), 2021-2032
Figure 61. Japan Affinity Chromatography Column for Mycotoxins Revenue (US$ Million), 2021-2032
Figure 62. South Korea Affinity Chromatography Column for Mycotoxins Revenue (US$ Million), 2021-2032
Figure 63. China Taiwan Affinity Chromatography Column for Mycotoxins Revenue (US$ Million), 2021-2032
Figure 64. India Affinity Chromatography Column for Mycotoxins Revenue (US$ Million), 2021-2032
Figure 65. Central and South America Affinity Chromatography Column for Mycotoxins Sales YoY (K Units), 2021-2032
Figure 66. Central and South America Affinity Chromatography Column for Mycotoxins Revenue YoY (US$ Million), 2021-2032
Figure 67. Central and South America Top 5 Manufacturers Affinity Chromatography Column for Mycotoxins Sales Revenue (US$ Million) in 2025
Figure 68. Central and South America Affinity Chromatography Column for Mycotoxins Sales Volume (K Units) by Application (2021-2032)
Figure 69. Central and South America Affinity Chromatography Column for Mycotoxins Sales Revenue (US$ Million) by Application (2021-2032)
Figure 70. Brazil Affinity Chromatography Column for Mycotoxins Revenue (US$ Million), 2021-2032
Figure 71. Argentina Affinity Chromatography Column for Mycotoxins Revenue (US$ Million), 2021-2032
Figure 72. Middle East, and Africa Affinity Chromatography Column for Mycotoxins Sales YoY (K Units), 2021-2032
Figure 73. Middle East and Africa Affinity Chromatography Column for Mycotoxins Revenue YoY (US$ Million), 2021-2032
Figure 74. Middle East and Africa Top 5 Manufacturers Affinity Chromatography Column for Mycotoxins Sales Revenue (US$ Million) in 2025
Figure 75. Middle East and Africa Affinity Chromatography Column for Mycotoxins Sales Volume (K Units) by Application (2021-2032)
Figure 76. Middle East and Africa Affinity Chromatography Column for Mycotoxins Sales Revenue (US$ Million) by Application (2021-2032)
Figure 77. GCC Countries Affinity Chromatography Column for Mycotoxins Revenue (US$ Million), 2021-2032
Figure 78. Turkey Affinity Chromatography Column for Mycotoxins Revenue (US$ Million), 2021-2032
Figure 79. Egypt Affinity Chromatography Column for Mycotoxins Revenue (US$ Million), 2021-2032
Figure 80. South Africa Affinity Chromatography Column for Mycotoxins Revenue (US$ Million), 2021-2032
Figure 81. Affinity Chromatography Column for Mycotoxins Industry Chain Mapping
Figure 82. Regional Affinity Chromatography Column for Mycotoxins Manufacturing Base Distribution (%)
Figure 83. Global Affinity Chromatography Column for Mycotoxins Production Market Share by Region (2021-2032)
Figure 84. Affinity Chromatography Column for Mycotoxins Production Process
Figure 85. Regional Affinity Chromatography Column for Mycotoxins Production Cost Structure
Figure 86. Channels of Distribution (Direct Vs Distribution)
Figure 87. Bottom-up and Top-down Approaches for This Report
Figure 88. Data Triangulation
Figure 89. Key Executives Interviewed
den_biaoTiZhungShi

KEY QUESTIONS ADDRESSED BY THE REPORT

What was the global market size of Affinity Chromatography Column for Mycotoxins in 2026?zhanKai
The global market size of Affinity Chromatography Column for Mycotoxins in 2026 was 220 Million USD.
What was the global market size of Affinity Chromatography Column for Mycotoxins in 2032?shouQi
Which region is expected to have the highest market share?shouQi
Which companies rank high in the global Affinity Chromatography Column for Mycotoxins market?shouQi
What is the annual compound growth rate of the global Affinity Chromatography Column for Mycotoxins market size from 2026 to 2032?shouQi
den_biaoTiZhungShi

Related Reports

Global Affinity Chromatography Column for Mycotoxins Market Outlook, In‑Depth Analysis & Forecast to 2032

Industry: Food & Beverages

Published Date: 2026-03-24

Pages: 191 Pages

Report ld: 6277414

CHOOSE LICENSE TYPE
tip

USD 4900.00

tip

USD 7350.00

tip

USD 9800.00

Add to Cart

Add to Cart

Buy Now

Buy Now

HAVE A QUESTION?
SIMON LEE

English,Chinese

Offline

HITESH

English, Hindi

Offline

TANG XIN

Japanese,English

Offline

SUNG-BIN YOON

SUNG-BIN YOON

+82-2883 1278

Korean, English

Offline

YUJIE TIAN

Chinese, English

Offline

DAMON

Chinese, English

Offline

General Email:

REPORT COVERAGE

den_ic8

DESCRIPTION

zhankai
den_ic7

OVERVIEW

den_ic7

MARKET SEGMENTATION

den_ic7

CHAPTER OUTLINE

den_ic7

WHY THIS REPORT

den_ic7

QYRESEARCH'S STRENGTHS

den_ic8

TABLE OF CONTENTS

den_ic8

TABLE OF FIGURES

den_ic8

RLEATED REPORTS

INTEREST IN THIS REPORT?

yangBenGet A Free Sample

baoJia Request For Quotation

OR

NEED A CUSTOMIZED REPORT?

DingZhiCustomized Report

biaoTi

WORLD WIDE OFFICE

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

Add to Cart

Add to Cart

Buy Now

Buy Now